1620228-47-8

Basic information

• Product Name: 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl 3-phenylpyrrolidine-1-carboxylate
• Synonyms: 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl 3-phenylpyrrolidine-1-carboxylate
• CAS NO: 1620228-47-8
• Molecular Weight: 393.291
• Mol File: 1620228-47-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl 3-phenylpyrrolidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl 3-phenylpyrrolidine-1-carboxylate(1620228-47-8)
• EPA Substance Registry System: 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl 3-phenylpyrrolidine-1-carboxylate(1620228-47-8)

Safety Data

• Hazardous Substances Data: 1620228-47-8(Hazardous Substances Data)

Upstream product

• 936-44-7 3-phenylpyrrolidine 
• 7693-44-9 4-bromophenyl chloroformate 
• 1620228-46-7 4-bromophenyl 3-phenylpyrrolidine-1-carboxylate 
• 73183-34-3 bis(pinacol)diborane 

Downstream Products

• 1620223-06-4 4-(4-oxo-3,4-dihydrophthalazin-1-yl)phenyl 3-phenylpyrrolidine-1-carboxylate 

Relevant articles and documents

PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS

The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective ROCK inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating cardiovascular, smooth muscle, oncologic, neuropathologic, autoimmune, fibrotic, and/or inflammatory disorders using the same.